↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant(2008).„Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4: 217-241.DOI:10.1016/S1574-1400(08)00012-1.
↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP.(2012).„ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID21948594.edit
↑Rosengren,A. H.;Jokubka,R.;Tojjar,D.;Granhall,C.;Hansson,O.;Li,D.-Q.;Nagaraj,V.;Reinbothe,T. M.i dr..(2009).„Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes”.Science327(5962): 217–20.DOI:10.1126/science.1176827.PMID19965390.
12Millan MJ;Newman-Tancredi A;Audinot Vi dr..(February 2000).„Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states”.Synapse35(2): 79–95.DOI:10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X.PMID10611634.